Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM
- PMID: 17900673
- DOI: 10.1016/j.ygyno.2007.08.064
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM
Abstract
Objective: CD24 is an established marker for poor prognosis in ovarian and other carcinomas. Acquisition of cytoplasmic CD24, as opposed to membranous expression, has been correlated with a higher invasiveness of tumor cells. Exosomes are small vesicles of endosomal origin that are often secreted by tumor cells. Given the emerging role of exosomes in tumor progression, we investigated whether cytoplasmic CD24 expression is correlated with the secretion of CD24 in exosomes.
Methods: We used CD24 transfected carcinoma cell lines, ovarian carcinoma cell lines and malignant ascites fluid of ovarian carcinoma patients. Exosomes were isolated via ultracentrifugation and sucrose density fractionation and subsequently examined by Western blot analysis and gelatine zymography. In tissue sections CD24 was detected by immunohistochemical staining.
Results: We show that CD24 is released by transfected as well as endogenously expressing cells in vesicles that represent exosomes. CD24 was also identified in exosomes isolated from ascites fluid of ovarian carcinoma patients. In 16 ovarian carcinomas analyzed no correlation between CD24 in tumor tissue sections and the appearance of CD24 in exosomes was detected. Furthermore, we provide evidence that the epithelial cell adhesion molecule (EpCAM), known to be overexpressed in ovarian carcinomas, is secreted in exosomes. The ascites exosomes contain gelatinolytic enzymes.
Conclusions: Our study identifies CD24 and EpCAM as cargo proteins of exosomes of cultured cell lines and malignant ascites. The exosome-associated proteolytic activity in the tumor vicinity might augment tumor invasion into the stroma.
Similar articles
-
Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.Int J Gynecol Cancer. 2012 May;22(4):546-52. doi: 10.1097/IGC.0b013e318241d9b9. Int J Gynecol Cancer. 2012. PMID: 22315094
-
Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.Gynecol Oncol. 2011 Aug;122(2):437-46. doi: 10.1016/j.ygyno.2011.04.035. Epub 2011 May 20. Gynecol Oncol. 2011. PMID: 21601258
-
Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.Cancer Lett. 2009 Jun 8;278(1):73-81. doi: 10.1016/j.canlet.2008.12.028. Epub 2009 Feb 1. Cancer Lett. 2009. PMID: 19188015
-
CD44 and EpCAM: cancer-initiating cell markers.Curr Mol Med. 2008 Dec;8(8):784-804. doi: 10.2174/156652408786733667. Curr Mol Med. 2008. PMID: 19075676 Review.
-
The biological significance and clinical applications of exosomes in ovarian cancer.Gynecol Oncol. 2016 Jul;142(1):199-205. doi: 10.1016/j.ygyno.2016.03.036. Epub 2016 Apr 10. Gynecol Oncol. 2016. PMID: 27058839 Free PMC article. Review.
Cited by
-
Exosomes in tumor microenvironment influence cancer progression and metastasis.J Mol Med (Berl). 2013 Apr;91(4):431-7. doi: 10.1007/s00109-013-1020-6. Epub 2013 Mar 22. J Mol Med (Berl). 2013. PMID: 23519402 Free PMC article. Review.
-
Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer.J Extracell Vesicles. 2015 Mar 31;4:25530. doi: 10.3402/jev.v4.25530. eCollection 2015. J Extracell Vesicles. 2015. PMID: 25833224 Free PMC article.
-
Exosomes in Cancer Microenvironment and Beyond: have we Overlooked these Extracellular Messengers?Cancer Microenviron. 2012 Dec;5(3):323-32. doi: 10.1007/s12307-012-0110-2. Epub 2012 May 15. Cancer Microenviron. 2012. PMID: 22585423 Free PMC article.
-
Extracellular Vesicles from Ovarian Carcinoma Cells Display Specific Glycosignatures.Biomolecules. 2015 Aug 4;5(3):1741-61. doi: 10.3390/biom5031741. Biomolecules. 2015. PMID: 26248080 Free PMC article.
-
Nanomaterials for Molecular Detection and Analysis of Extracellular Vesicles.Nanomaterials (Basel). 2023 Jan 28;13(3):524. doi: 10.3390/nano13030524. Nanomaterials (Basel). 2023. PMID: 36770486 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous